PTEN and neoplasm: PTEN was selected for our immunohistochemical study, because loss of PTEN expression showed correlation with disease-related death, lymph node metastasis (Depowski et al, 2001), and development of distant metastases in 88 tumour samples (Piekarski and Biernat, 2006).